In COVID-19 patients, lymphopenia could be a prognostic predictor for disease as CD4+ T cells, CD8+ T cells, B cells, and NK cells decreased, with a significant reduction of CD8+ (22). The gene discussed is CD8A; the disease is lymphopenia.